Growth hormone therapy in children; research and practice - A review

Paulo Ferrez Collett-Solberg, Alexander A. L. Jorge, Margaret C. S. Boguszewski, Bradley S. Miller, Catherine Seut Yhoke Choong, Pinchas Cohen, Andrew R. Hoffman, Xiaoping Luo, Sally Radovick, Paul Saenger

Research output: Contribution to journalReview article

8 Citations (Scopus)

Abstract

Short stature remains the most common reason for referral to a pediatric Endocrinologist and its management remains a challenge. One of the main controversies is the diagnosis of idiopathic short stature and the role of new technologies for genetic investigation of children with inadequate growth.

Complexities in management of children with short stature includes selection of who should receive interventions such as recombinant human growth hormone, and how should this agent dose be adjusted during treatment. Should anthropometrical data be the primary determinant or should biochemical and genetic data be used to improve growth response and safety? Furthermore, what is considered a suboptimal response to growth hormone therapy and how should this be managed?

Treatment of children with short stature remains a "hot" topic and more data is needed in several areas. These issues are reviewed in this paper.

Original languageEnglish
Pages (from-to)20-32
Number of pages13
JournalGrowth Hormone & IGF Research
Volume44
DOIs
Publication statusPublished - Feb 2019

Cite this

Collett-Solberg, P. F., Jorge, A. A. L., Boguszewski, M. C. S., Miller, B. S., Choong, C. S. Y., Cohen, P., ... Saenger, P. (2019). Growth hormone therapy in children; research and practice - A review. Growth Hormone & IGF Research, 44, 20-32. https://doi.org/10.1016/j.ghir.2018.12.004
Collett-Solberg, Paulo Ferrez ; Jorge, Alexander A. L. ; Boguszewski, Margaret C. S. ; Miller, Bradley S. ; Choong, Catherine Seut Yhoke ; Cohen, Pinchas ; Hoffman, Andrew R. ; Luo, Xiaoping ; Radovick, Sally ; Saenger, Paul. / Growth hormone therapy in children; research and practice - A review. In: Growth Hormone & IGF Research. 2019 ; Vol. 44. pp. 20-32.
@article{474ec51d873c48df848a8bf4e1d24624,
title = "Growth hormone therapy in children; research and practice - A review",
abstract = "Short stature remains the most common reason for referral to a pediatric Endocrinologist and its management remains a challenge. One of the main controversies is the diagnosis of idiopathic short stature and the role of new technologies for genetic investigation of children with inadequate growth.Complexities in management of children with short stature includes selection of who should receive interventions such as recombinant human growth hormone, and how should this agent dose be adjusted during treatment. Should anthropometrical data be the primary determinant or should biochemical and genetic data be used to improve growth response and safety? Furthermore, what is considered a suboptimal response to growth hormone therapy and how should this be managed?Treatment of children with short stature remains a {"}hot{"} topic and more data is needed in several areas. These issues are reviewed in this paper.",
keywords = "Short stature, Growth, Growth hormone, Genetic, IDIOPATHIC SHORT STATURE, SITTING HEIGHT/HEIGHT RATIO, IDENTIFY GENETIC CAUSES, FOR-GESTATIONAL-AGE, FACTOR-I TREATMENT, B NPR2 GENE, COST-EFFECTIVENESS, HETEROZYGOUS MUTATIONS, DIAGNOSTIC-VALUE, 2ND NEOPLASMS",
author = "Collett-Solberg, {Paulo Ferrez} and Jorge, {Alexander A. L.} and Boguszewski, {Margaret C. S.} and Miller, {Bradley S.} and Choong, {Catherine Seut Yhoke} and Pinchas Cohen and Hoffman, {Andrew R.} and Xiaoping Luo and Sally Radovick and Paul Saenger",
year = "2019",
month = "2",
doi = "10.1016/j.ghir.2018.12.004",
language = "English",
volume = "44",
pages = "20--32",
journal = "Growth Hormone & IGF Research",
issn = "1096-6374",
publisher = "Churchill Livingstone",

}

Collett-Solberg, PF, Jorge, AAL, Boguszewski, MCS, Miller, BS, Choong, CSY, Cohen, P, Hoffman, AR, Luo, X, Radovick, S & Saenger, P 2019, 'Growth hormone therapy in children; research and practice - A review' Growth Hormone & IGF Research, vol. 44, pp. 20-32. https://doi.org/10.1016/j.ghir.2018.12.004

Growth hormone therapy in children; research and practice - A review. / Collett-Solberg, Paulo Ferrez; Jorge, Alexander A. L.; Boguszewski, Margaret C. S.; Miller, Bradley S.; Choong, Catherine Seut Yhoke; Cohen, Pinchas; Hoffman, Andrew R.; Luo, Xiaoping; Radovick, Sally; Saenger, Paul.

In: Growth Hormone & IGF Research, Vol. 44, 02.2019, p. 20-32.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Growth hormone therapy in children; research and practice - A review

AU - Collett-Solberg, Paulo Ferrez

AU - Jorge, Alexander A. L.

AU - Boguszewski, Margaret C. S.

AU - Miller, Bradley S.

AU - Choong, Catherine Seut Yhoke

AU - Cohen, Pinchas

AU - Hoffman, Andrew R.

AU - Luo, Xiaoping

AU - Radovick, Sally

AU - Saenger, Paul

PY - 2019/2

Y1 - 2019/2

N2 - Short stature remains the most common reason for referral to a pediatric Endocrinologist and its management remains a challenge. One of the main controversies is the diagnosis of idiopathic short stature and the role of new technologies for genetic investigation of children with inadequate growth.Complexities in management of children with short stature includes selection of who should receive interventions such as recombinant human growth hormone, and how should this agent dose be adjusted during treatment. Should anthropometrical data be the primary determinant or should biochemical and genetic data be used to improve growth response and safety? Furthermore, what is considered a suboptimal response to growth hormone therapy and how should this be managed?Treatment of children with short stature remains a "hot" topic and more data is needed in several areas. These issues are reviewed in this paper.

AB - Short stature remains the most common reason for referral to a pediatric Endocrinologist and its management remains a challenge. One of the main controversies is the diagnosis of idiopathic short stature and the role of new technologies for genetic investigation of children with inadequate growth.Complexities in management of children with short stature includes selection of who should receive interventions such as recombinant human growth hormone, and how should this agent dose be adjusted during treatment. Should anthropometrical data be the primary determinant or should biochemical and genetic data be used to improve growth response and safety? Furthermore, what is considered a suboptimal response to growth hormone therapy and how should this be managed?Treatment of children with short stature remains a "hot" topic and more data is needed in several areas. These issues are reviewed in this paper.

KW - Short stature

KW - Growth

KW - Growth hormone

KW - Genetic

KW - IDIOPATHIC SHORT STATURE

KW - SITTING HEIGHT/HEIGHT RATIO

KW - IDENTIFY GENETIC CAUSES

KW - FOR-GESTATIONAL-AGE

KW - FACTOR-I TREATMENT

KW - B NPR2 GENE

KW - COST-EFFECTIVENESS

KW - HETEROZYGOUS MUTATIONS

KW - DIAGNOSTIC-VALUE

KW - 2ND NEOPLASMS

U2 - 10.1016/j.ghir.2018.12.004

DO - 10.1016/j.ghir.2018.12.004

M3 - Review article

VL - 44

SP - 20

EP - 32

JO - Growth Hormone & IGF Research

JF - Growth Hormone & IGF Research

SN - 1096-6374

ER -